Myostatin/Smad3 in Spinal Muscular Atrophy: Biomarkers of Disease Severity and Treatment Response. [PDF]
Riolo G +11 more
europepmc +1 more source
Humanistic and Economic Burden of Spinal Muscular Atrophy in the Gulf Region. [PDF]
Elezbawy B +8 more
europepmc +1 more source
Multi-Omics Landscape of Paraspinal Muscles in Spinal Muscular Atrophy With Scoliosis. [PDF]
Wang Z, Zhao J, Huang X, Chen W, Shen J.
europepmc +1 more source
Il capitolo descrive le attività del terzo biennio dello Spinal Muscular Atrophy Laboratory, un laboratorio di management che mira a sostenere i sistemi sanitari (sia regionali che aziendali), i professionisti e i pazienti, con l’intento di migliorare ...
Tozzi, Valeria D. +2 more
core
Addressing the Global Disparities in Access to Treatment in Spinal Muscular Atrophy. [PDF]
Koutsioumpa C +3 more
europepmc +1 more source
Serum p-tau181 and p-tau217 levels in adolescents and adults with 5q spinal muscular atrophy. [PDF]
Stapf CD +15 more
europepmc +1 more source
Glymphatic Dysfunction in Children With Type 2 and 3 Spinal Muscular Atrophy. [PDF]
Lan S +10 more
europepmc +1 more source
Therapeutic advances in spinal muscular atrophy: a review of clinical, safety, and economic considerations. [PDF]
Belančić A +3 more
europepmc +1 more source
Abnormal auditory neural activity in individuals with spinal muscular atrophy. [PDF]
Rance G, Yiu EM.
europepmc +1 more source

